BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31447709)

  • 1. Psychometric Properties of the Short Form of the Fear of Cancer Recurrence Inventory (FCRI) in Chinese Breast Cancer Survivors.
    Peng L; Huang W; Zhang W; Xu Y; Lu F; Zhong L; Chen X; Xu S; Chen W; Li M
    Front Psychiatry; 2019; 10():537. PubMed ID: 31447709
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
    Fardell JE; Jones G; Smith AB; Lebel S; Thewes B; Costa D; Tiller K; Simard S; Feldstain A; Beattie S; McCallum M; ; Butow P
    Psychooncology; 2018 Feb; 27(2):492-499. PubMed ID: 28755462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric evaluation of the Fear of Cancer Recurrence Inventory (FCRI) and development of a short version in patients with follicular lymphoma.
    Xu RH; Yu S; Yang Y; Ng S; Xu B; Dong D
    Disabil Rehabil; 2022 Dec; 44(24):7508-7515. PubMed ID: 34623949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.
    Hovdenak Jakobsen I; Jeppesen MM; Simard S; Thaysen HV; Laurberg S; Juul T
    J Cancer Surviv; 2018 Dec; 12(6):723-732. PubMed ID: 30128857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
    Tutelman PR; Chambers CT; Heathcote LC; Fernandez CV; Flanders A; Patton M; Schulte FSM; Guilcher GMT; Simard S; MacLeod J; Stern M
    Psychooncology; 2022 Jun; 31(6):911-919. PubMed ID: 35018689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
    Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.
    Thewes B; Bell ML; Butow P
    Psychooncology; 2013 Sep; 22(9):2059-63. PubMed ID: 23408595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and screening capacity of the FCR-1r for fear of cancer recurrence in long-term colorectal cancer survivors.
    Lyhne JD; Smith AB; Timm S; Simard S; Jensen LH; Frostholm L; Fink P
    Support Care Cancer; 2023 Nov; 31(12):690. PubMed ID: 37950072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fear of cancer recurrence in colorectal cancer survivors.
    Custers JAE; Gielissen MFM; Janssen SHV; de Wilt JHW; Prins JB
    Support Care Cancer; 2016 Feb; 24(2):555-562. PubMed ID: 26108170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism.
    Ng DWL; Kwong A; Suen D; Chan M; Or A; Ng SS; Foo CC; Fielding BFS; Lam WWT
    Psychooncology; 2019 Jun; 28(6):1243-1251. PubMed ID: 30932279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study.
    Shin J; Shin DW; Lee J; Hwang J; Lee JE; Cho B; Song YM
    BMC Cancer; 2022 Apr; 22(1):414. PubMed ID: 35428224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale.
    Custers JAE; Kwakkenbos L; van de Wal M; Prins JB; Thewes B
    Psychooncology; 2018 Nov; 27(11):2609-2615. PubMed ID: 29843189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear of cancer recurrence among cancer survivors in Singapore.
    Mahendran R; Liu J; Kuparasundram S; Simard S; Chan YH; Kua EH; Griva K
    Singapore Med J; 2021 Jun; 62(6):305-310. PubMed ID: 31989183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and comorbidity of clinical levels of fear of cancer recurrence.
    Simard S; Savard J
    J Cancer Surviv; 2015 Sep; 9(3):481-91. PubMed ID: 25603948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on the Fear of Cancer Recurrence Inventory (FCRI).
    Smith AB; Costa D; Galica J; Lebel S; Tauber N; van Helmondt SJ; Zachariae R
    Psychol Res Behav Manag; 2020; 13():1257-1268. PubMed ID: 33376421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer.
    Lane BE; Garland SN; Chalifour K; Eaton G; Lebel S; Galica J; Maheu C; Simard S
    J Cancer Surviv; 2019 Dec; 13(6):842-851. PubMed ID: 31468324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fear of cancer recurrence in males diagnosed with breast cancer.
    Dalton K; Waterman M; Wassersug R; Garland SN
    Support Care Cancer; 2021 Nov; 29(11):6183-6186. PubMed ID: 34023951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between fear of cancer recurrence, spiritual well-being and psychological resilience in non-metastatic breast cancer survivors during the COVID-19 outbreak.
    Koral L; Cirak Y
    Psychooncology; 2021 Oct; 30(10):1765-1772. PubMed ID: 33982371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric Characteristics of the Fear of Cancer Recurrence Inventory-Severity Subscale Among Korean Cancer Survivors.
    Park SY
    J Prev Med Public Health; 2024 May; ():. PubMed ID: 38853579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fear of Cancer Recurrence in peritoneal malignancy patients following treatment: a cross-sectional study.
    Taher R; Carr NJ; Vanderpuye N; Stanford S
    J Cancer Surviv; 2023 Apr; 17(2):300-308. PubMed ID: 35900688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.